Work with us
Better treatments for children and young people affected by cancer are in our sight. No one part of the ecosystem can tackle this challenge alone. Those who join us are the ones ready to rewrite the playbook - people with innovative ideas for new therapeutics and approaches.
Whether you’re a researcher with a therapeutic opportunity, a potential partner or an impact investor, we want to hear from you.
Researchers
We partner with researchers to advance drug discovery and development efforts for childhood cancer treatments.
Going the extra mile
By collaborating with researchers and bringing together state-of-the-art facilities, expert resources, and a collaborative network of passionate professionals, we're aiming to overcome common obstacles in the way of development.
Support designed with you in mind
Our innovative approach provides your project with a unique combination of resourcing, expertise and investment that gives it the best chance of success.
Partners
By re-thinking conventional approaches to drug discovery and development, we are removing barriers and bringing promising new therapeutics to children and young people with cancer.
We’re looking for new partners from academia, industry, the non-profit sector and more.
Non-profits & charitable research funders
We need like-minded charities, research funders and foundations to get involved. Together we can increase the amount of funding available for drug discovery and development - improving the scale and diversity of research we progress in cancers affecting children and young people.
We're sparking change in our sector. This is an opportunity to join a movement and collaborate with like-minded individuals to advance treatments for childhood cancers more quickly and efficiently than ever before.
Wendy Jacquemet-Ross
Head of Partnerships, Childhood Cancer, LifeArc
News and events
We are creating a consortium united in the unwavering belief that we can challenge conventional approaches and accelerate translation of promising ideas into new therapies for children and young people affected by cancer.
Stay up to date on our latest news, events and research.
Building the future of childhood cancer medicines
Listen to Tony Hickson and Labiotech’s Dylan Kissane discuss how C-Further is accelerating child-first medicines for children and young people with cancer.
Inside C-Further’s operating model
In the article , we outline our framework and how our hybrid model creates long-term value and clinical impact.
What makes a strong C-Further collaboration proposal
In this article, we outline our evaluation framework and share what researchers and future partners from academia and industry should consider when preparing a collaboration proposal.
Interview with BiotechTV
BiotechTV’s Amy Brown speaks with C-Further JSC member Tony Hickson about transforming paediatric oncology through C-Further’s independent drug discovery model and how it differs from traditional biotech companies and grant funders.